Abstract:As a known steroid hormone, cortisol is involved in gluconeogenesis. Uninterrupted cortisol secretion has fatal effects, both physically and psychologically, because cortisol counteracts the immune response. Moxibustion (Mox) treatment is a traditional technique used in East Asia, which therapeutically transfers heat to certain points on the body surface. In the present study, the effect of Mox treatment on stress hormone secretion was investigated using a mouse model of starvation, in which Mox was applied on… Show more
“…Furthermore, in this study, the serum Corticosterone level of the Bio-clean II treated rats was significantly reduced in a duration dependent manner when compared to the inflammation control post-exposure to LPS. This agrees with the study of Hwang et al, in which treatment with Mox (a traditional therapeutic procedure used in Oriental Medicine for treating infectious diseases, ulcerative colitis, rheumatoid arthritis, cancer and pain) was found to significantly reduce high cortisol levels in a dose-dependent manner in mice [44]. It is also in agreement with the work of Lim et al in which Lindera obtusiloba extracts, at concentrations that were not affected by cell viability, significantly decreased luciferase activity in response to cortisol in a concentrationdependent manner [45].…”
Background: Bio-Clean II has been previously shown to fight viral infection, boost immunity, and possesses anti-inflammatory properties by regulating the serum level of inflammatory cytokines, as well as T-Helper 4 and Cytotoxic T-Lymphocytes in rats exposed to purified bacterial lipopolysaccharide (LPS). Aim: The aim of this study is to assess the effects of Bio-Clean II on the C-reactive protein (CRP), corticosterone (CORT) and anti-phospholipid antibodies (aPLs) levels in rats exposed to bacterial lipopolysaccharide (LPS) using animal model. Materials and Methods: A total of 36 male Wistar rats weighing 150g±50g (mean±SD) were purchased and randomly assigned to six (6) groups of 6 rats each. Group 1, 2, 3, 5 and 6 were induced with a single dose of 5mg/Kg of purified LPS® (E.coli 0127:B8, Sigma-Aldrich, St. Louis, USA), administered through intraperitoneal route using 1ml sterile needle and syringe, except for group 4 which served as the zero control (given water and food only throughout the experiment). Group 1 served as the inflammation control. Group 2 which served as the positive control received 50 mg diclofenac/kg [bid] and 500 mg ciprofloxacin/kg [bid] (positive control) in place of the Bio-Clean. Group 3 which served as the negative control received sterile phosphate buffer saline (PBS). While rats in group 5 and group 6 were treated orally with the herbal remedy “Bio-Clean II” for 7 days and 14 days, respectively. After which, the rats were killed and a cardiac blood specimen was taken from each rat and transferred to plain bottles to clot. Serum was obtained from the clotted blood by centrifugation. The serum levels of C-reactive protein, corticosterone and antiphospholipid antibodies were assayed using ELISA kits, supplied by Elabscience Biotechnology Inc, USA. Data generated were subjected to Statistical Package for Social Scientists-Version 20 (SPSS-20). Results: The outcome of this results show that the serum level of C-reactive protein of the 7 days (1.05±0.06ng/ml) and 14 days (0.93±0.05ng/ml) Bio-Clean II treated rats was found to be significantly lower (p=0.002 and p=0.000, respectively) when compared to the inflammation control group (1.70±0.07ng/ml). Similarly, the serum level of anti-phospholipid antibodies of the 7 days (6.40±0.67 Uml) and 14 days (4.27±0.66 U/ml) Bio-Clean II treated rats was found to be significantly lower (p=0.02 and p=0.008, respectively) when compared to the inflammation control group (16.47±1.53 Uml). Meanwhile, the corticosterone level of the 7 days Bio-clean treated rats (9.40±1.30ng/mL) was found to be non-significantly lower (p=0.812) in comparison to the inflammation control (13.50±2.50ng/mL); while that of the 14 days Bio-clean II treated rats (6.80±1.00ng/mL) was significantly lower (p=0.026). Conclusion: The outcom
“…Furthermore, in this study, the serum Corticosterone level of the Bio-clean II treated rats was significantly reduced in a duration dependent manner when compared to the inflammation control post-exposure to LPS. This agrees with the study of Hwang et al, in which treatment with Mox (a traditional therapeutic procedure used in Oriental Medicine for treating infectious diseases, ulcerative colitis, rheumatoid arthritis, cancer and pain) was found to significantly reduce high cortisol levels in a dose-dependent manner in mice [44]. It is also in agreement with the work of Lim et al in which Lindera obtusiloba extracts, at concentrations that were not affected by cell viability, significantly decreased luciferase activity in response to cortisol in a concentrationdependent manner [45].…”
Background: Bio-Clean II has been previously shown to fight viral infection, boost immunity, and possesses anti-inflammatory properties by regulating the serum level of inflammatory cytokines, as well as T-Helper 4 and Cytotoxic T-Lymphocytes in rats exposed to purified bacterial lipopolysaccharide (LPS). Aim: The aim of this study is to assess the effects of Bio-Clean II on the C-reactive protein (CRP), corticosterone (CORT) and anti-phospholipid antibodies (aPLs) levels in rats exposed to bacterial lipopolysaccharide (LPS) using animal model. Materials and Methods: A total of 36 male Wistar rats weighing 150g±50g (mean±SD) were purchased and randomly assigned to six (6) groups of 6 rats each. Group 1, 2, 3, 5 and 6 were induced with a single dose of 5mg/Kg of purified LPS® (E.coli 0127:B8, Sigma-Aldrich, St. Louis, USA), administered through intraperitoneal route using 1ml sterile needle and syringe, except for group 4 which served as the zero control (given water and food only throughout the experiment). Group 1 served as the inflammation control. Group 2 which served as the positive control received 50 mg diclofenac/kg [bid] and 500 mg ciprofloxacin/kg [bid] (positive control) in place of the Bio-Clean. Group 3 which served as the negative control received sterile phosphate buffer saline (PBS). While rats in group 5 and group 6 were treated orally with the herbal remedy “Bio-Clean II” for 7 days and 14 days, respectively. After which, the rats were killed and a cardiac blood specimen was taken from each rat and transferred to plain bottles to clot. Serum was obtained from the clotted blood by centrifugation. The serum levels of C-reactive protein, corticosterone and antiphospholipid antibodies were assayed using ELISA kits, supplied by Elabscience Biotechnology Inc, USA. Data generated were subjected to Statistical Package for Social Scientists-Version 20 (SPSS-20). Results: The outcome of this results show that the serum level of C-reactive protein of the 7 days (1.05±0.06ng/ml) and 14 days (0.93±0.05ng/ml) Bio-Clean II treated rats was found to be significantly lower (p=0.002 and p=0.000, respectively) when compared to the inflammation control group (1.70±0.07ng/ml). Similarly, the serum level of anti-phospholipid antibodies of the 7 days (6.40±0.67 Uml) and 14 days (4.27±0.66 U/ml) Bio-Clean II treated rats was found to be significantly lower (p=0.02 and p=0.008, respectively) when compared to the inflammation control group (16.47±1.53 Uml). Meanwhile, the corticosterone level of the 7 days Bio-clean treated rats (9.40±1.30ng/mL) was found to be non-significantly lower (p=0.812) in comparison to the inflammation control (13.50±2.50ng/mL); while that of the 14 days Bio-clean II treated rats (6.80±1.00ng/mL) was significantly lower (p=0.026). Conclusion: The outcom
“…The effect of moxibustion on stress, including stress hormones and sympathetic activity, has primarily been investigated in stress-induced animal models [23,24]. In terms of clinical studies, there has been only one study examining the effect of moxibustion on stress-related variables [16].…”
Section: Discussionmentioning
confidence: 99%
“…However, there is limited evidence regarding the effectiveness of moxibustion on stress. Studies have reported the effects of moxibustion on stress hormones (i.e., cortisol) in stressed animal models with conditions like starvation and gastric ulcer [23,24], but its effects on stress hormones in human individuals are not yet established. The effect of moxibustion on mental stress is currently unknown.…”
This study aimed to evaluate the effects of an 8-week self-administered moxibustion program on blood pressure, stress, sleep quality, and quality of life in hypertensive patients. We compared its effects with those of self-acupressure to assess the feasibility of using moxibustion as a self-management method for hypertension. Forty-six subjects were recruited and randomly assigned to a moxibustion group and an acupressure group. The moxibustion group applied moxa sticks to seven acupoints by themselves five times a week for 8 weeks, while the acupressure group placed acupressure patches on the same acupoints by themselves. Systolic and diastolic blood pressures were measured. Stress was assessed with plasma epinephrine, plasma norepinephrine, and the Perceived Stress Scale (PSS). Sleep quality and quality of life were evaluated using the Pittsburgh Sleep Quality Index (PSQI) and the World Health Organization Quality of Life-Brief Version (WHOQOL-BREF), respectively. Systolic and diastolic blood pressures decreased in the moxibustion and acupressure groups to a similar extent after the 8-week intervention. Plasma epinephrine and norepinephrine levels and PSQI variables were not changed in both groups. PSS decreased only in the moxibustion group. Quality of life related to physical health and environmental health, as assessed by the WHOQOL-BREF, significantly improved to a similar degree in both groups. Both self-administered moxibustion and acupressure therapies were effective in reducing blood pressure in hypertensive patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.